We are a pure play CDMO, specialized in development and GMP manufacturing of viral vectors.
We can help guide you through your process development, tech transfer, validation and QA, all the way to a complete CMC package and documentation
An Institut Mérieux Company
We have been a pioneer in developing and producing viral vectors since 1994.
We are grounded in the Mérieux family’s legacy of biology and vaccine expertise since 1897.
We are a pure CDMO player contributing to the success of your immunotherapy and gene therapy innovations.
first viral vector facility in Europe
(France & USA)
years of experience
in viral vectors (manufacturing)
- Fill & finish up to
Your solution provider
Developing and manufacturing viral vectors for over 25 years
Dedicated project management
Effective quality control capabilities essential for your success
Flexibility within our contracts
Talented teams to deliver the highest level of services